Treatment with ODQ slightly attenuated the positive effects of nitric oxide on glucose consumption and lactated secretion (Supplementary Figure 1A), which indicated that the nitric oxide-stimulated glycolysis in ovarian cancer cells might be also mediated by sGC-cGMP signaling. The gene discussed is SGCB; the disease is ovarian carcinoma.